These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8791250)

  • 1. Intellectual impairment in neurofibromatosis 1.
    Ferner RE; Hughes RA; Weinman J
    J Neurol Sci; 1996 Jun; 138(1-2):125-33. PubMed ID: 8791250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychological profile in adults with neurofibromatosis type 1 compared to a control group.
    Descheemaeker MJ; Plasschaert E; Frijns JP; Legius E
    J Intellect Disabil Res; 2013 Sep; 57(9):874-86. PubMed ID: 23095048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1.
    Hyman SL; Shores A; North KN
    Neurology; 2005 Oct; 65(7):1037-44. PubMed ID: 16217056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cognitive impairment in adults with neurofibromatosis type 1].
    Uttner I; Wahlländer-Danek U; Danek A
    Fortschr Neurol Psychiatr; 2003 Mar; 71(3):157-62. PubMed ID: 12624853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive control in adolescents with neurofibromatosis type 1.
    Rowbotham I; Pit-ten Cate IM; Sonuga-Barke EJ; Huijbregts SC
    Neuropsychology; 2009 Jan; 23(1):50-60. PubMed ID: 19210032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does attention-deficit-hyperactivity disorder exacerbate executive dysfunction in children with neurofibromatosis type 1?
    Payne JM; Arnold SS; Pride NA; North KN
    Dev Med Child Neurol; 2012 Oct; 54(10):898-904. PubMed ID: 22845611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficit in phonological processes: a characteristic of the neuropsychological profile of children with NF1.
    Chaix Y; Lauwers-Cancès V; Faure-Marie N; Gentil C; Lelong S; Schweitzer E; Rodriguez D; Iannuzzi S; Kemlin I; Dorison N; Rivier F; Carniero M; Preclaire E; Barbarot S; Lion-François L; Castelnau P
    Child Neuropsychol; 2018 May; 24(4):558-574. PubMed ID: 28393676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Learning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit-hyperactivity disorder.
    Hyman SL; Arthur Shores E; North KN
    Dev Med Child Neurol; 2006 Dec; 48(12):973-7. PubMed ID: 17109785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocognitive dysfunction in children with neurofibromatosis type 1.
    Rosser TL; Packer RJ
    Curr Neurol Neurosci Rep; 2003 Mar; 3(2):129-36. PubMed ID: 12583841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofibromatosis type 1: new insights into neurocognitive issues.
    Acosta MT; Gioia GA; Silva AJ
    Curr Neurol Neurosci Rep; 2006 Mar; 6(2):136-43. PubMed ID: 16522267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between cognitive dysfunction, gait, and motor impairment in children and adolescents with neurofibromatosis type 1.
    Champion JA; Rose KJ; Payne JM; Burns J; North KN
    Dev Med Child Neurol; 2014 May; 56(5):468-74. PubMed ID: 24387687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attention and Motor Learning in Adult Patients with Neurofibromatosis Type 1.
    Castricum J; Tulen JHM; Taal W; Rietman AB; Elgersma Y
    J Atten Disord; 2022 Feb; 26(4):563-572. PubMed ID: 33978520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Executive dysfunction in children with neurofibromatosis type 1: a study of action planning.
    Roy A; Roulin JL; Charbonnier V; Allain P; Fasotti L; Barbarot S; Stalder JF; Terrien A; Le Gall D
    J Int Neuropsychol Soc; 2010 Nov; 16(6):1056-63. PubMed ID: 20682087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Social functioning in adults with neurofibromatosis type 1.
    Pride NA; Crawford H; Payne JM; North KN
    Res Dev Disabil; 2013 Oct; 34(10):3393-9. PubMed ID: 23911645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motor impairment in children with Neurofibromatosis type 1: Effect of the comorbidity with language disorders.
    Iannuzzi S; Albaret JM; Chignac C; Faure-Marie N; Barry I; Karsenty C; Chaix Y
    Brain Dev; 2016 Feb; 38(2):181-7. PubMed ID: 26321374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive function and academic performance in children with neurofibromatosis type 1.
    North K; Joy P; Yuille D; Cocks N; Hutchins P
    Dev Med Child Neurol; 1995 May; 37(5):427-36. PubMed ID: 7768342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The adverse influence of attention-deficit disorder with or without hyperactivity on cognition in neurofibromatosis type 1.
    Lidzba K; Granström S; Lindenau J; Mautner VF
    Dev Med Child Neurol; 2012 Oct; 54(10):892-7. PubMed ID: 22881119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of cognitive, behavioural and academic difficulties in NF1.
    Geoffray MM; Robinson L; Ramamurthy K; Manderson L; O'Flaherty J; Lehtonen A; Tordjman S; Green J; Vassallo G; Garg S
    J Psychiatr Res; 2021 Aug; 140():545-550. PubMed ID: 34182240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of ADHD on the cognitive and academic functioning of children with NF1.
    Pride NA; Payne JM; North KN
    Dev Neuropsychol; 2012; 37(7):590-600. PubMed ID: 23066937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive functions in neurofibromatosis type 1 patients and unaffected siblings.
    Erdoğan-Bakar E; Cinbiş M; Ozyürek H; Kiriş N; Altunbaşak S; Anlar B
    Turk J Pediatr; 2009; 51(6):565-71. PubMed ID: 20196390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.